| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | IRF2BP2 NRG1 URI1 ATN1 NELFA BCLAF1 NCBP1 DAXX DOK2 ZMIZ1 MED13L BCL9 SRCAP KMT2E ARID1A WNK1 TAB3 GAB2 MAGI2 KMT2C PER2 TCERG1 MDC1 MLLT3 MYOCD SCRIB PRDM16 UTF1 TNS3 RAB11FIP3 | 3.37e-09 | 1356 | 132 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | IRF2BP2 NRG1 URI1 ATN1 BCLAF1 DAXX ZMIZ1 MED13L BCL9 SRCAP KMT2E ARID1A KMT2C PER2 TCERG1 MYOCD PRDM16 UTF1 | 3.29e-08 | 562 | 132 | 18 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | IRF2BP2 NRG1 URI1 ATN1 BCLAF1 DAXX DOK2 ZMIZ1 MED13L BCL9 SRCAP KMT2E ARID1A WNK1 GAB2 MAGI2 KMT2C PER2 TCERG1 MDC1 MYOCD SCRIB PRDM16 UTF1 TNS3 RAB11FIP3 | 3.54e-08 | 1160 | 132 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator activity | ATN1 DAXX ZMIZ1 BCL9 SRCAP KMT2E ARID1A KMT2C PER2 TCERG1 MYOCD PRDM16 UTF1 | 1.12e-07 | 303 | 132 | 13 | GO:0003713 |
| GeneOntologyMolecularFunction | SMAD binding | 2.27e-05 | 86 | 132 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 7.03e-05 | 65 | 132 | 5 | GO:0070063 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP42 ARHGEF18 PLEKHG2 GMIP ARHGEF25 ARHGAP31 PLCB1 AGAP4 AGAP6 TNS3 AGAP1 | 5.54e-04 | 507 | 132 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP42 ARHGEF18 PLEKHG2 GMIP ARHGEF25 ARHGAP31 PLCB1 AGAP4 AGAP6 TNS3 AGAP1 | 5.54e-04 | 507 | 132 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | kinase binding | NRG1 CACNB1 ATN1 NBEAL1 PER1 PTPN23 DAXX DOK2 WNK1 GAB2 CCNT2 PER2 PTPRJ SCRIB PRKAG2 MAP2K7 | 6.69e-04 | 969 | 132 | 16 | GO:0019900 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | IRF2BP2 NRG1 URI1 ATN1 CIART NELFA BCLAF1 PER1 ETV5 DAXX SIM2 ARID1A ATXN1L TENM2 SOX13 NEDD4 ZNF469 PER2 TCERG1 SUDS3 GLI3 CHD5 PLCB1 ZFHX3 MYOCD PRDM16 | 6.25e-07 | 1399 | 131 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | IRF2BP2 NRG1 URI1 ATN1 CIART NELFA BCLAF1 PER1 ETV5 DAXX SIM2 ARID1A ATXN1L TENM2 SOX13 NEDD4 ZNF469 PER2 TCERG1 SUDS3 GLI3 CHD5 PLCB1 ZFHX3 MYOCD PRDM16 | 7.55e-07 | 1413 | 131 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | IRF2BP2 URI1 ATN1 PER1 ETV5 DAXX SIM2 ARID1A ATXN1L TENM2 SOX13 NEDD4 ZNF469 PER2 TCERG1 SUDS3 GLI3 CHD5 ZFHX3 MYOCD PRDM16 | 2.98e-06 | 1053 | 131 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXN1 FOXN4 NELFA BCLAF1 PER1 ETV5 NCBP1 DAXX ZMIZ1 MLXIP BCL9 ZNF467 CCNT2 KMT2C TCERG1 GLI3 MDC1 AUTS2 ZFHX3 ELF4 MYOCD PRDM16 UTF1 SMAD9 | 6.46e-06 | 1390 | 131 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 GAB2 SLC4A2 FASN PTPRJ BTNL3 GLI3 PLCB1 KIT PRDM16 IL4R | 1.07e-05 | 789 | 131 | 17 | GO:0002521 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 SLC4A2 FASN PTPRJ BTNL3 GLI3 PLCB1 KIT IL4R | 1.39e-05 | 640 | 131 | 15 | GO:1903131 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | NRG1 AMPH TRABD2B SGIP1 CLASP1 WASF3 PTPN23 SYNPO STIL WNK1 TENM2 MAGI2 CRACD PHLDB1 PTPRJ WASF2 NAF1 PLCB1 AUTS2 KIT MAP2K7 IL4R RAB11FIP3 | 1.56e-05 | 1366 | 131 | 23 | GO:0051130 |
| GeneOntologyBiologicalProcess | central nervous system development | NRG1 ATN1 FOXN4 MINK1 WASF3 TACC2 ZMIZ1 STIL ARID1A ATXN1L SOX13 LSR C2CD3 PTPRJ SUDS3 GLI3 CHD5 SEC24B PLCB1 SCRIB SMAD9 | 2.10e-05 | 1197 | 131 | 21 | GO:0007417 |
| GeneOntologyBiologicalProcess | tube development | FOXN1 ROBO4 COL15A1 FOXN4 ETV5 ZMIZ1 STIL SIM2 ARID1A WNK1 ATXN1L SLC4A2 NEDD4 C2CD3 PTPRJ GLI3 WASF2 SEC24B MYOCD SCRIB KIT WNK4 TNS3 | 2.35e-05 | 1402 | 131 | 23 | GO:0035295 |
| GeneOntologyBiologicalProcess | hemopoiesis | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 KMT2E ARID1A ATXN1L SOX13 GAB2 SLC4A2 FASN PTPRJ BTNL3 GLI3 WASF2 PLCB1 MLLT3 KIT PRDM16 IL4R | 2.88e-05 | 1223 | 131 | 21 | GO:0030097 |
| GeneOntologyBiologicalProcess | T cell differentiation | FOXN1 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 SLC4A2 BTNL3 GLI3 KIT IL4R | 3.32e-05 | 382 | 131 | 11 | GO:0030217 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 SLC4A2 PTPRJ BTNL3 GLI3 KIT IL4R | 3.86e-05 | 537 | 131 | 13 | GO:0030098 |
| GeneOntologyBiologicalProcess | cell activation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 KMT2E ARID1A SOX13 GAB2 SLC4A2 NEDD4 PTPRJ BTNL3 GLI3 PLCB1 ELF4 MYOCD SCRIB KIT IL4R WNK4 PEAR1 | 4.29e-05 | 1356 | 131 | 22 | GO:0001775 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 6.94e-05 | 109 | 131 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | NRG1 TRABD2B CLASP1 SYNPO STIL TENM2 CRACD PHLDB1 PTPRJ WASF2 AUTS2 KIT RAB11FIP3 | 8.72e-05 | 582 | 131 | 13 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.00e-04 | 226 | 131 | 8 | GO:0045580 | |
| GeneOntologyBiologicalProcess | T cell activation | FOXN1 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 SLC4A2 NEDD4 BTNL3 GLI3 ELF4 SCRIB KIT IL4R | 1.51e-04 | 701 | 131 | 14 | GO:0042110 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 1.60e-04 | 17 | 131 | 3 | GO:0042921 | |
| GeneOntologyBiologicalProcess | leukocyte activation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 KMT2E ARID1A SOX13 GAB2 SLC4A2 NEDD4 PTPRJ BTNL3 GLI3 ELF4 SCRIB KIT IL4R WNK4 | 1.79e-04 | 1186 | 131 | 19 | GO:0045321 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 1.91e-04 | 18 | 131 | 3 | GO:0031958 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.34e-04 | 136 | 131 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.34e-04 | 136 | 131 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | circadian regulation of translation | 2.38e-04 | 4 | 131 | 2 | GO:0097167 | |
| GeneOntologyBiologicalProcess | cochlear nucleus development | 2.38e-04 | 4 | 131 | 2 | GO:0021747 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | NRG1 CLASP1 MINK1 PTPN23 ZMIZ1 ARID1A WNK1 SOX13 SLC4A2 MAGI2 PTPRJ NUAK1 GLI3 ZFHX3 SCRIB IL4R | 2.66e-04 | 927 | 131 | 16 | GO:0030155 |
| GeneOntologyBiologicalProcess | tube morphogenesis | FOXN1 ROBO4 COL15A1 FOXN4 ETV5 ZMIZ1 STIL ARID1A WNK1 NEDD4 C2CD3 PTPRJ GLI3 WASF2 SEC24B MYOCD SCRIB WNK4 | 2.72e-04 | 1125 | 131 | 18 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.04e-04 | 266 | 131 | 8 | GO:0045619 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 3.18e-04 | 93 | 131 | 5 | GO:0034243 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transport | 3.53e-04 | 22 | 131 | 3 | GO:0010766 | |
| GeneOntologyBiologicalProcess | brain development | NRG1 MINK1 TACC2 ZMIZ1 STIL ARID1A ATXN1L C2CD3 SUDS3 GLI3 CHD5 SEC24B PLCB1 SCRIB SMAD9 | 3.70e-04 | 859 | 131 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.95e-04 | 5 | 131 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 3.95e-04 | 5 | 131 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | extrathymic T cell differentiation | 3.95e-04 | 5 | 131 | 2 | GO:0033078 | |
| GeneOntologyBiologicalProcess | negative regulation of pancreatic juice secretion | 3.95e-04 | 5 | 131 | 2 | GO:0090188 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 3.95e-04 | 5 | 131 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 4.60e-04 | 24 | 131 | 3 | GO:0150105 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 4.66e-04 | 101 | 131 | 5 | GO:0002028 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | FOXN1 IRF2BP2 MINK1 ZNF683 ZMIZ1 ARID1A SOX13 SLC4A2 NEDD4 PTPRJ BTNL3 GLI3 ELF4 SCRIB KIT IL4R | 4.69e-04 | 976 | 131 | 16 | GO:0046649 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 4.72e-04 | 155 | 131 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ROBO4 NRG1 MINK1 PTPN23 ZMIZ1 ARID1A WNK1 TENM2 SOX13 SLC4A2 MAGI2 CDH22 GLI3 SCRIB KIT IL4R PEAR1 | 4.76e-04 | 1077 | 131 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ROBO4 NRG1 MINK1 WASF3 ARHGEF18 CPNE5 ARHGEF25 TENM2 NEDD4 CDH22 PTPRJ GLI3 WASF2 SEC24B AUTS2 TRAK2 SCRIB KIT | 5.54e-04 | 1194 | 131 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 5.56e-04 | 105 | 131 | 5 | GO:0032784 | |
| GeneOntologyBiologicalProcess | response to ionomycin | 5.91e-04 | 6 | 131 | 2 | GO:1904636 | |
| GeneOntologyBiologicalProcess | cellular response to ionomycin | 5.91e-04 | 6 | 131 | 2 | GO:1904637 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 5.91e-04 | 6 | 131 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | tongue development | 6.55e-04 | 27 | 131 | 3 | GO:0043586 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | ARHGAP42 NRG1 NCBP1 DAXX STIL GMIP MAGI2 NAF1 PLCB1 ANTXR1 MYOCD SCRIB PRKAG2 KIT MAP2K7 AGAP4 AGAP6 WNK4 TNS3 AGAP1 | 6.92e-04 | 1430 | 131 | 20 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of platelet-derived growth factor receptor signaling pathway | 7.30e-04 | 28 | 131 | 3 | GO:0010640 | |
| GeneOntologyBiologicalProcess | positive regulation of G1/S transition of mitotic cell cycle | 7.35e-04 | 64 | 131 | 4 | GO:1900087 | |
| GeneOntologyBiologicalProcess | head development | NRG1 MINK1 TACC2 ZMIZ1 STIL ARID1A ATXN1L C2CD3 SUDS3 GLI3 CHD5 SEC24B PLCB1 SCRIB SMAD9 | 7.43e-04 | 919 | 131 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | circulatory system development | FOXN1 ROBO4 NRG1 COL15A1 HCN4 FOXN4 ZMIZ1 STIL ARID1A WNK1 NEDD4 C2CD3 PTPRJ GLI3 WASF2 SEC24B ANTXR1 ANKRD17 MYOCD KIT | 7.68e-04 | 1442 | 131 | 20 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix assembly | 8.11e-04 | 29 | 131 | 3 | GO:1901201 | |
| GeneOntologyBiologicalProcess | thymic T cell selection | 8.11e-04 | 29 | 131 | 3 | GO:0045061 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | ARHGAP42 NRG1 DAXX STIL GMIP MAGI2 NAF1 ANTXR1 SCRIB PRKAG2 KIT MAP2K7 AGAP4 AGAP6 WNK4 AGAP1 | 8.19e-04 | 1028 | 131 | 16 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 8.23e-04 | 7 | 131 | 2 | GO:1903288 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 8.49e-04 | 239 | 131 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle phase transition | 9.09e-04 | 117 | 131 | 5 | GO:1901992 | |
| GeneOntologyCellularComponent | nuclear body | CIART NELFA BCLAF1 PTPN23 DAXX SIM2 SRCAP KMT2E TENM2 TCERG1 SUDS3 GLI3 CHD5 MDC1 PLCB1 ZFHX3 ELF4 RNF111 | 1.54e-05 | 903 | 132 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | anchoring junction | ATN1 CLASP1 FBF1 SYNPO TENM2 SLC4A2 MAGI2 LSR CDH22 PTPRJ ARHGAP31 WASF2 MDC1 TNKS1BP1 SCRIB KIT WNK4 TNS3 | 4.28e-05 | 976 | 132 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | chromatin | FOXN1 FOXN4 ETV5 DAXX ZMIZ1 MLXIP SIM2 SRCAP KMT2E ARID1A SOX13 NEDD4 UBR5 SUDS3 CHD5 PLCB1 ANKRD17 ZFHX3 ELF4 MYOCD TNKS1BP1 CDCA5 SMAD9 | 5.03e-05 | 1480 | 132 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 3.47e-04 | 22 | 132 | 3 | GO:0098890 | |
| GeneOntologyCellularComponent | cell-cell junction | FBF1 SYNPO TENM2 MAGI2 LSR CDH22 PTPRJ WASF2 TNKS1BP1 SCRIB KIT WNK4 | 3.73e-04 | 591 | 132 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | basal cortex | 8.14e-04 | 7 | 132 | 2 | GO:0045180 | |
| MousePheno | pale yolk sac | 3.81e-06 | 110 | 117 | 8 | MP:0001722 | |
| MousePheno | abnormal pericardium morphology | 1.90e-05 | 225 | 117 | 10 | MP:0000288 | |
| MousePheno | herniated abdominal wall | 2.04e-05 | 20 | 117 | 4 | MP:0000757 | |
| MousePheno | arrhythmic circadian behavior persistence | 4.63e-05 | 9 | 117 | 3 | MP:0020472 | |
| MousePheno | abnormal circadian behavior persistence | 8.98e-05 | 11 | 117 | 3 | MP:0020471 | |
| Domain | PH_dom-like | ARHGAP42 NBEAL1 ARHGEF18 DOK2 PLEKHG2 ARHGEF25 GAB2 PHLDB1 PLCB1 AGAP4 AGAP6 TNS3 AGAP1 | 9.56e-06 | 426 | 131 | 13 | IPR011993 |
| Domain | PH | ARHGAP42 ARHGEF18 DOK2 PLEKHG2 ARHGEF25 GAB2 PHLDB1 AGAP4 AGAP6 AGAP1 | 2.69e-05 | 278 | 131 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGAP42 ARHGEF18 DOK2 PLEKHG2 ARHGEF25 GAB2 PHLDB1 AGAP4 AGAP6 AGAP1 | 2.77e-05 | 279 | 131 | 10 | PS50003 |
| Domain | PH_domain | ARHGAP42 ARHGEF18 DOK2 PLEKHG2 ARHGEF25 GAB2 PHLDB1 AGAP4 AGAP6 AGAP1 | 2.86e-05 | 280 | 131 | 10 | IPR001849 |
| Domain | - | ARHGAP42 ARHGEF18 DOK2 PLEKHG2 ARHGEF25 GAB2 PHLDB1 AGAP4 AGAP6 TNS3 AGAP1 | 9.88e-05 | 391 | 131 | 11 | 2.30.29.30 |
| Domain | SCAR/WAVE_fam | 1.46e-04 | 3 | 131 | 2 | IPR028288 | |
| Domain | Period_circadian-like_C | 1.46e-04 | 3 | 131 | 2 | IPR022728 | |
| Domain | Period_C | 1.46e-04 | 3 | 131 | 2 | PF12114 | |
| Domain | Anthrax_toxin_rcpt_extracel | 1.46e-04 | 3 | 131 | 2 | IPR008400 | |
| Domain | Anth_Ig | 1.46e-04 | 3 | 131 | 2 | PF05587 | |
| Domain | - | 1.72e-04 | 74 | 131 | 5 | 3.40.50.410 | |
| Domain | PH | 2.15e-04 | 229 | 131 | 8 | PF00169 | |
| Domain | SMAD_FHA_domain | 4.82e-04 | 52 | 131 | 4 | IPR008984 | |
| Domain | PAS_fold_3 | 5.39e-04 | 23 | 131 | 3 | IPR013655 | |
| Domain | PAS_3 | 5.39e-04 | 23 | 131 | 3 | PF08447 | |
| Domain | PAS-assoc_C | 6.13e-04 | 24 | 131 | 3 | IPR000700 | |
| Domain | VWF_A | 6.64e-04 | 99 | 131 | 5 | IPR002035 | |
| Domain | OSR1_C | 7.19e-04 | 6 | 131 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 7.19e-04 | 6 | 131 | 2 | IPR024678 | |
| Domain | PAC | 7.79e-04 | 26 | 131 | 3 | IPR001610 | |
| Domain | PAC | 7.79e-04 | 26 | 131 | 3 | PS50113 | |
| Domain | PAC | 7.79e-04 | 26 | 131 | 3 | SM00086 | |
| Domain | RPEL | 1.00e-03 | 7 | 131 | 2 | PS51073 | |
| Domain | RPEL | 1.00e-03 | 7 | 131 | 2 | SM00707 | |
| Domain | RPEL | 1.00e-03 | 7 | 131 | 2 | PF02755 | |
| Domain | RPEL_repeat | 1.00e-03 | 7 | 131 | 2 | IPR004018 | |
| Domain | ArfGap | 1.08e-03 | 29 | 131 | 3 | SM00105 | |
| Domain | ARFGAP | 1.08e-03 | 29 | 131 | 3 | PS50115 | |
| Domain | ArfGap | 1.08e-03 | 29 | 131 | 3 | PF01412 | |
| Domain | ArfGAP | 1.08e-03 | 29 | 131 | 3 | IPR001164 | |
| Domain | FHA_DOMAIN | 1.31e-03 | 31 | 131 | 3 | PS50006 | |
| Domain | FHA | 1.31e-03 | 31 | 131 | 3 | PF00498 | |
| Domain | PAS | 1.44e-03 | 32 | 131 | 3 | SM00091 | |
| Domain | PAS | 1.72e-03 | 34 | 131 | 3 | PS50112 | |
| Domain | PAS | 1.72e-03 | 34 | 131 | 3 | IPR000014 | |
| Domain | - | 2.03e-03 | 36 | 131 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 2.03e-03 | 36 | 131 | 3 | IPR000253 | |
| Domain | VWFA | 2.65e-03 | 82 | 131 | 4 | PS50234 | |
| Domain | VWA | 2.89e-03 | 84 | 131 | 4 | SM00327 | |
| Domain | SET | 4.11e-03 | 46 | 131 | 3 | SM00317 | |
| Domain | WH2 | 4.20e-03 | 14 | 131 | 2 | SM00246 | |
| Domain | WW | 4.37e-03 | 47 | 131 | 3 | PF00397 | |
| Domain | WW | 4.63e-03 | 48 | 131 | 3 | SM00456 | |
| Domain | SET_dom | 5.20e-03 | 50 | 131 | 3 | IPR001214 | |
| Domain | SET | 5.20e-03 | 50 | 131 | 3 | PS50280 | |
| Domain | WH2 | 5.49e-03 | 16 | 131 | 2 | PF02205 | |
| Domain | WW_DOMAIN_1 | 5.49e-03 | 51 | 131 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 5.49e-03 | 51 | 131 | 3 | PS50020 | |
| Domain | WW_dom | 5.80e-03 | 52 | 131 | 3 | IPR001202 | |
| Domain | C2_dom | 6.02e-03 | 164 | 131 | 5 | IPR000008 | |
| Domain | Acyl_Trfase/lysoPLipase | 6.20e-03 | 17 | 131 | 2 | IPR016035 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP42 WASF3 ARHGEF18 PLEKHG2 GMIP ARHGEF25 ARHGAP31 WASF2 | 4.19e-05 | 175 | 103 | 8 | MM15599 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP42 WASF3 ARHGEF18 PLEKHG2 GMIP ARHGEF25 ARHGAP31 WASF2 | 5.98e-05 | 184 | 103 | 8 | M41809 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PHACTR2 CLASP1 MINK1 PLEKHG2 STIL MLXIP WNK1 TAB3 GAB2 NEDD4 LSR PHLDB1 C2CD3 TCERG1 SEC24B ANKRD17 TNKS1BP1 SCRIB MAP2K7 WNK4 TNS3 KIF1C | 1.69e-12 | 861 | 132 | 22 | 36931259 |
| Pubmed | WASF3 PTPN23 MED13L WNK1 KMT2C PHLDB1 UBR5 CHD5 PLCB1 AUTS2 TNKS1BP1 SCRIB PRDM16 | 4.01e-12 | 225 | 132 | 13 | 12168954 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | URI1 CLASP1 BCLAF1 PER1 NCBP1 DAXX GMIP MLXIP WNK1 SOX13 GAB2 PHLDB1 UBR5 NAF1 SEC24B MLLT3 TNKS1BP1 TRAK2 MAP2K7 CNOT3 TNS3 AGAP1 | 6.27e-11 | 1038 | 132 | 22 | 26673895 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 ATN1 CLASP1 NELFA BCLAF1 MINK1 USP24 DAXX BCL9 GPRIN1 CCNT2 FASN NAF1 MDC1 ANKRD17 TNKS1BP1 SCRIB CCDC9 CNOT3 | 1.26e-10 | 774 | 132 | 19 | 15302935 |
| Pubmed | IRF2BP2 ATN1 ETV5 PPP1R13B ZMIZ1 BCL9 SRCAP ARID1A ATXN1L SOX13 TAB3 KMT2C TCERG1 SUDS3 GLI3 CHD5 MDC1 SEC24B AUTS2 ANKRD17 ZFHX3 ELF4 PRDM16 CNOT3 | 8.51e-10 | 1429 | 132 | 24 | 35140242 | |
| Pubmed | BCLAF1 FBF1 SYNPO KMT2C NUAK1 ARHGAP31 CHD5 MDC1 PLCB1 AUTS2 ANKRD17 TNKS1BP1 AGAP4 AGAP6 AGAP1 | 1.87e-09 | 529 | 132 | 15 | 14621295 | |
| Pubmed | BCLAF1 USP24 PPP1R13B PTPN23 SRCAP ARID1A GPRIN1 TAB3 KMT2C FASN TCERG1 MDC1 SEC24B TNKS1BP1 SCRIB | 3.08e-09 | 549 | 132 | 15 | 38280479 | |
| Pubmed | CACNB1 SGIP1 CLASP1 HCN4 PRR36 BCLAF1 MINK1 ARHGEF18 SYNPO BCL9 TENM2 NEDD4 LRIG2 MAGI2 UBR5 WASF2 PLCB1 ANKRD17 SCRIB | 4.61e-09 | 963 | 132 | 19 | 28671696 | |
| Pubmed | 5.65e-09 | 102 | 132 | 8 | 9734811 | ||
| Pubmed | CLASP1 MLXIP MED13L TENM2 NEDD4 MAGI2 CRACD PHLDB1 PER2 UBR5 PPIP5K1 TRAK2 SCRIB | 5.84e-09 | 407 | 132 | 13 | 12693553 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ATN1 ZMIZ1 BCL9 ARID1A ATXN1L SOX13 KMT2C SUDS3 MDC1 AUTS2 ZFHX3 PRDM16 | 1.09e-08 | 351 | 132 | 12 | 38297188 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | AMPH MINK1 ARHGEF18 SYNPO GPRIN1 NEDD4 UBR5 AGAP4 AGAP6 AGAP1 | 1.33e-07 | 281 | 132 | 10 | 28706196 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CLASP1 MINK1 TACC2 MED13L ARID1A NEDD4 INTS6 WASF2 ZFHX3 AGAP4 AGAP6 AGAP1 REV1 | 1.45e-07 | 536 | 132 | 13 | 15840001 |
| Pubmed | CLASP1 MINK1 TACC2 MED13L ARID1A NEDD4 INTS6 WASF2 ZFHX3 AGAP4 AGAP6 AGAP1 REV1 | 1.52e-07 | 538 | 132 | 13 | 10512203 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PER1 MLXIP MED13L BCL9 SRCAP ARID1A WNK1 KMT2C FASN PHLDB1 C2CD3 PER2 NUAK1 CHD5 TNKS1BP1 PRDM16 IL4R RAB11FIP3 | 2.15e-07 | 1105 | 132 | 18 | 35748872 |
| Pubmed | PPP1R13B PTPN23 DAXX SYNPO WNK1 GAB2 KMT2C TCERG1 ARHGAP31 PLCB1 ANKRD17 RNF111 | 3.72e-07 | 486 | 132 | 12 | 20936779 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 BCLAF1 PTPN23 TACC2 SRCAP GPRIN1 WNK1 CRACD FASN TCERG1 WASF2 NAF1 SEC24B ANKRD17 TNKS1BP1 SCRIB | 5.55e-07 | 934 | 132 | 16 | 33916271 |
| Pubmed | FOXN4 ETV5 TACC2 ARID1A ZNF467 SOX13 KMT2C LSR PER2 GLI3 ZFHX3 PRDM16 RNF111 SMAD9 | 5.64e-07 | 709 | 132 | 14 | 22988430 | |
| Pubmed | FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue. | 7.35e-07 | 19 | 132 | 4 | 34348145 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ATN1 ARHGEF18 BCL9 KMT2E WNK1 NEDD4 ZNF469 ARHGAP31 CHD5 MDC1 WNK4 | 8.24e-07 | 430 | 132 | 11 | 35044719 |
| Pubmed | 9.31e-07 | 268 | 132 | 9 | 33640491 | ||
| Pubmed | ATN1 FBF1 PER1 SRCAP ARID1A INTS6 ZNF469 UBR5 SUDS3 GLI3 CHD5 NAF1 ANKRD17 ZFHX3 SCRIB PRDM16 MAP2K7 | 1.20e-06 | 1116 | 132 | 17 | 31753913 | |
| Pubmed | BCLAF1 MINK1 GPRIN1 GAB2 SLC30A6 LRIG2 LSR UBR5 GLI3 WASF2 SEC24B ZFHX3 SCRIB AGAP1 | 1.66e-06 | 777 | 132 | 14 | 35844135 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | NRG1 MINK1 SLC4A2 LSR PHLDB1 PTPRJ ARHGAP31 WASF2 PLCB1 SCRIB TNS3 AGAP1 | 1.93e-06 | 569 | 132 | 12 | 30639242 |
| Pubmed | 1.98e-06 | 152 | 132 | 7 | 38360978 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CLASP1 PPP1R13B DAXX TACC2 SRCAP ARID1A WNK1 SOX13 TCERG1 UBR5 TNKS1BP1 CNOT3 | 2.70e-06 | 588 | 132 | 12 | 38580884 |
| Pubmed | Machine learning helps identify CHRONO as a circadian clock component. | 2.95e-06 | 8 | 132 | 3 | 24737000 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.05e-06 | 231 | 132 | 8 | 16452087 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 3.10e-06 | 59 | 132 | 5 | 28813667 | |
| Pubmed | 3.15e-06 | 105 | 132 | 6 | 9628581 | ||
| Pubmed | IRF2BP2 PHACTR2 NELFA BCLAF1 SRCAP ARID1A CRACD FASN TCERG1 WASF2 MDC1 | 3.95e-06 | 506 | 132 | 11 | 30890647 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.41e-06 | 9 | 132 | 3 | 12640130 | |
| Pubmed | Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. | 4.41e-06 | 9 | 132 | 3 | 22767893 | |
| Pubmed | IRF2BP2 CLASP1 NELFA BCLAF1 ETV5 MED13L BCL9 ARID1A ATXN1L CCNT2 KMT2C FASN TCERG1 UBR5 MAP2K7 CDCA5 | 4.73e-06 | 1103 | 132 | 16 | 34189442 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.29e-06 | 10 | 132 | 3 | 20664521 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.99e-06 | 184 | 132 | 7 | 32908313 | |
| Pubmed | CACNB1 AMPH SGIP1 HCN4 BCLAF1 MINK1 USP24 PER1 SYNPO TACC2 GPRIN1 TENM2 TAB3 MAGI2 PLCB1 CNOT3 | 7.07e-06 | 1139 | 132 | 16 | 36417873 | |
| Pubmed | 7.64e-06 | 347 | 132 | 9 | 17114649 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 8.62e-06 | 11 | 132 | 3 | 15381706 | |
| Pubmed | The Regulatory Factor ZFHX3 Modifies Circadian Function in SCN via an AT Motif-Driven Axis. | 8.62e-06 | 11 | 132 | 3 | 26232227 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PHACTR2 MINK1 PPP1R13B GPRIN1 LSR FASN PTPRJ WASF2 SEC24B TNKS1BP1 SCRIB | 1.11e-05 | 565 | 132 | 11 | 25468996 |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23977055 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21793695 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27021954 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33327223 | ||
| Pubmed | Constant darkness is a circadian metabolic signal in mammals. | 1.43e-05 | 2 | 132 | 2 | 16421573 | |
| Pubmed | Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. | 1.43e-05 | 2 | 132 | 2 | 11389837 | |
| Pubmed | Circadian regulation of central ethanol sensitivity by the mPer2 gene. | 1.43e-05 | 2 | 132 | 2 | 19523042 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11207804 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15009158 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35475497 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20370466 | ||
| Pubmed | cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. | 1.43e-05 | 2 | 132 | 2 | 18487196 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35810166 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21704025 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23110090 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12112872 | ||
| Pubmed | Circadian Modulation of Neurons and Astrocytes Controls Synaptic Plasticity in Hippocampal Area CA1. | 1.43e-05 | 2 | 132 | 2 | 33053337 | |
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 1.43e-05 | 2 | 132 | 2 | 33824309 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24603368 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12775559 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17996461 | ||
| Pubmed | Circadian gene expression is resilient to large fluctuations in overall transcription rates. | 1.43e-05 | 2 | 132 | 2 | 19078963 | |
| Pubmed | The circadian clock and tumor suppression by mammalian period genes. | 1.43e-05 | 2 | 132 | 2 | 15817328 | |
| Pubmed | Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. | 1.43e-05 | 2 | 132 | 2 | 29863500 | |
| Pubmed | Low reproductive success in Per1 and Per2 mutant mouse females due to accelerated ageing? | 1.43e-05 | 2 | 132 | 2 | 18367514 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22910690 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19477955 | ||
| Pubmed | Mice lacking Period 1 and Period 2 circadian clock genes exhibit blue cone photoreceptor defects. | 1.43e-05 | 2 | 132 | 2 | 23351077 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22294159 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34160105 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35442829 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12054191 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9920673 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15959842 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19840112 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30452546 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17202855 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12693867 | ||
| Pubmed | Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. | 1.43e-05 | 2 | 132 | 2 | 23039899 | |
| Pubmed | Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. | 1.43e-05 | 2 | 132 | 2 | 16899520 | |
| Pubmed | Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice. | 1.43e-05 | 2 | 132 | 2 | 21624349 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31260634 | ||
| Pubmed | Phase shifts and Per gene expression in mouse suprachiasmatic nucleus. | 1.43e-05 | 2 | 132 | 2 | 12824769 | |
| Pubmed | Physiological and Molecular Dissection of Daily Variance in Exercise Capacity. | 1.43e-05 | 2 | 132 | 2 | 31006590 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 36361751 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24091726 | ||
| Pubmed | Deregulated expression of the Per1 and Per2 in human gliomas. | 1.43e-05 | 2 | 132 | 2 | 20481271 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25113964 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29377512 | ||
| Pubmed | Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. | 1.43e-05 | 2 | 132 | 2 | 17971899 | |
| Pubmed | Time-place learning and memory persist in mice lacking functional Per1 and Per2 clock genes. | 1.43e-05 | 2 | 132 | 2 | 24336415 | |
| Pubmed | Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC. | 1.43e-05 | 2 | 132 | 2 | 29846116 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23024437 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17715397 | ||
| Pubmed | T cell development from kit-negative progenitors in the Foxn1Delta/Delta mutant thymus. | 1.43e-05 | 2 | 132 | 2 | 18178831 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 36350921 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24770415 | ||
| Pubmed | Modulation of myocardin function by the ubiquitin E3 ligase UBR5. | 1.43e-05 | 2 | 132 | 2 | 20167605 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34632336 | ||
| Interaction | YWHAG interactions | PHACTR2 CLASP1 BCLAF1 MINK1 USP24 SYNPO PLEKHG2 MLXIP WNK1 TAB3 GAB2 NEDD4 CRACD LSR PHLDB1 C2CD3 TCERG1 NUAK1 WASF2 SEC24B ANKRD17 PPIP5K1 SCRIB TNS3 AGAP1 KIF1C | 7.76e-08 | 1248 | 129 | 26 | int:YWHAG |
| Interaction | GSC interactions | 8.66e-08 | 87 | 129 | 8 | int:GSC | |
| Interaction | YWHAH interactions | PHACTR2 CLASP1 MINK1 PLEKHG2 STIL MLXIP WNK1 ATXN1L TAB3 GAB2 NEDD4 LSR PHLDB1 C2CD3 TCERG1 NUAK1 WASF2 SEC24B ANKRD17 TNKS1BP1 SCRIB TNS3 AGAP1 KIF1C | 1.19e-07 | 1102 | 129 | 24 | int:YWHAH |
| Interaction | TNRC6A interactions | FBF1 STIL ARID1A WNK1 KMT2C UBR5 GLI3 MDC1 SEC24B ANKRD17 TNKS1BP1 CNOT3 | 2.53e-07 | 280 | 129 | 12 | int:TNRC6A |
| Interaction | NCK2 interactions | ARHGAP42 ATN1 NELFA MINK1 WASF3 SYNPO DOK2 CPNE5 PRR16 WASF2 KIT | 1.00e-06 | 262 | 129 | 11 | int:NCK2 |
| Interaction | TSC1 interactions | URI1 ATN1 CLASP1 FBF1 MINK1 TENM2 NEDD4 FASN PHLDB1 SEC24B SCRIB KIF1C | 4.18e-06 | 366 | 129 | 12 | int:TSC1 |
| Interaction | YWHAZ interactions | NRG1 CLASP1 NELFA MINK1 WASF3 ARHGEF18 SYNPO TACC2 MLXIP ARID1A WNK1 TAB3 GAB2 NEDD4 CRACD LSR PHLDB1 PER2 MDC1 ANKRD17 SCRIB AGAP1 KIF1C | 9.89e-06 | 1319 | 129 | 23 | int:YWHAZ |
| Interaction | CEP85 interactions | 1.33e-05 | 169 | 129 | 8 | int:CEP85 | |
| Interaction | PAX7 interactions | 1.51e-05 | 124 | 129 | 7 | int:PAX7 | |
| Interaction | TLX1 interactions | 1.72e-05 | 175 | 129 | 8 | int:TLX1 | |
| Interaction | OCLN interactions | MINK1 PPP1R13B GPRIN1 SLC4A2 SLC30A6 NEDD4 LSR PHLDB1 WASF2 SEC24B ANTXR1 TNKS1BP1 SCRIB | 1.98e-05 | 500 | 129 | 13 | int:OCLN |
| Interaction | FANCD2OS interactions | 2.15e-05 | 26 | 129 | 4 | int:FANCD2OS | |
| Interaction | TSG101 interactions | PPP1R13B PTPN23 DAXX NEDD4 FASN SEC24B TNKS1BP1 PRDM16 RNF111 RAB11FIP3 | 2.59e-05 | 303 | 129 | 10 | int:TSG101 |
| Interaction | YWHAQ interactions | PHACTR2 ZNF280D CLASP1 MINK1 MLXIP WNK1 TAB3 GAB2 NEDD4 LSR FASN PHLDB1 WASF2 ANKRD17 SCRIB WNK4 TNS3 AGAP1 SMAD9 KIF1C | 2.83e-05 | 1118 | 129 | 20 | int:YWHAQ |
| Interaction | HNF1B interactions | 3.10e-05 | 190 | 129 | 8 | int:HNF1B | |
| Interaction | BICD1 interactions | 3.39e-05 | 250 | 129 | 9 | int:BICD1 | |
| Interaction | RAC1 interactions | ARHGAP42 FBF1 MINK1 WASF3 PLEKHG2 GMIP GPRIN1 ARHGEF25 SLC4A2 NEDD4 LSR FASN PTPRJ ARHGAP31 WASF2 ANTXR1 SCRIB TNS3 AGAP1 | 4.65e-05 | 1063 | 129 | 19 | int:RAC1 |
| Interaction | AR interactions | IRF2BP2 ATN1 NELFA ETV5 DAXX ZMIZ1 MED13L BCL9 SRCAP ARID1A ATXN1L KMT2C UBR5 SUDS3 GLI3 MDC1 ZFHX3 REPS2 | 6.20e-05 | 992 | 129 | 18 | int:AR |
| Interaction | YWHAB interactions | URI1 CLASP1 NELFA MINK1 WASF3 MLXIP WNK1 GAB2 NEDD4 LSR PHLDB1 NUAK1 WASF2 ANKRD17 SCRIB TNS3 AGAP1 KIF1C | 8.20e-05 | 1014 | 129 | 18 | int:YWHAB |
| Interaction | THOC2 interactions | 8.46e-05 | 219 | 129 | 8 | int:THOC2 | |
| Interaction | WWTR1 interactions | USP24 PPP1R13B PTPN23 SRCAP ARID1A GPRIN1 TAB3 TCERG1 SEC24B TNKS1BP1 SCRIB | 8.67e-05 | 422 | 129 | 11 | int:WWTR1 |
| Interaction | TBR1 interactions | 8.84e-05 | 113 | 129 | 6 | int:TBR1 | |
| Interaction | TBXT interactions | 1.02e-04 | 116 | 129 | 6 | int:TBXT | |
| Interaction | EGR2 interactions | 1.17e-04 | 171 | 129 | 7 | int:EGR2 | |
| Interaction | YWHAE interactions | CACNB1 CLASP1 MINK1 WASF3 NCBP1 TACC2 MLXIP WNK1 TAB3 GAB2 NEDD4 CRACD LSR PHLDB1 PER2 NUAK1 NAF1 ANKRD17 AGAP1 KIF1C | 1.41e-04 | 1256 | 129 | 20 | int:YWHAE |
| Interaction | SMAD3 interactions | ZMIZ1 ARID1A NEDD4 MAGI2 LSR GLI3 ZFHX3 MYOCD PRDM16 RNF111 SMAD9 | 1.44e-04 | 447 | 129 | 11 | int:SMAD3 |
| Interaction | CNOT2 interactions | 1.51e-04 | 178 | 129 | 7 | int:CNOT2 | |
| Interaction | SP7 interactions | 1.51e-04 | 304 | 129 | 9 | int:SP7 | |
| Interaction | TLE3 interactions | IRF2BP2 ATN1 ZMIZ1 BCL9 ARID1A ATXN1L UBR5 AUTS2 ZFHX3 TNKS1BP1 | 1.56e-04 | 376 | 129 | 10 | int:TLE3 |
| Interaction | SMAD7 interactions | 1.68e-04 | 127 | 129 | 6 | int:SMAD7 | |
| Interaction | EYA4 interactions | 1.73e-04 | 243 | 129 | 8 | int:EYA4 | |
| Interaction | NCK1 interactions | 1.78e-04 | 244 | 129 | 8 | int:NCK1 | |
| Interaction | TOB1 interactions | 1.78e-04 | 44 | 129 | 4 | int:TOB1 | |
| Interaction | PAX9 interactions | 1.91e-04 | 130 | 129 | 6 | int:PAX9 | |
| Interaction | LCK interactions | MINK1 PPP1R13B DOK2 GPRIN1 GAB2 SLC30A6 LSR TNKS1BP1 SCRIB KIT MAP2K7 | 1.95e-04 | 463 | 129 | 11 | int:LCK |
| Interaction | CRX interactions | 2.34e-04 | 254 | 129 | 8 | int:CRX | |
| Interaction | FLOT1 interactions | FBF1 MINK1 PPP1R13B SYNPO GMIP GPRIN1 ARHGEF25 LSR ELF4 TNKS1BP1 SCRIB | 2.43e-04 | 475 | 129 | 11 | int:FLOT1 |
| Interaction | PML interactions | IRF2BP2 NELFA NCBP1 DAXX SYNPO TACC2 INTS6 FASN PER2 TCERG1 UBR5 MDC1 SEC24B ELF4 TNKS1BP1 RNF111 | 3.09e-04 | 933 | 129 | 16 | int:PML |
| Interaction | ASH2L interactions | 3.11e-04 | 265 | 129 | 8 | int:ASH2L | |
| Interaction | XYLT1 interactions | 3.13e-04 | 21 | 129 | 3 | int:XYLT1 | |
| Cytoband | 7q36.1 | 6.43e-05 | 74 | 132 | 4 | 7q36.1 | |
| Cytoband | 17q21-q22 | 1.22e-04 | 6 | 132 | 2 | 17q21-q22 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.85e-05 | 206 | 84 | 7 | 682 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 6.28e-05 | 17 | 84 | 3 | 1291 | |
| GeneFamily | ArfGAPs | 4.77e-04 | 33 | 84 | 3 | 395 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.22e-04 | 34 | 84 | 3 | 487 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.62e-03 | 50 | 84 | 3 | 721 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.45e-03 | 16 | 84 | 2 | 14 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.59e-03 | 66 | 84 | 3 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRG1 CLASP1 WASF3 USP24 ZMIZ1 STIL MED13L NEDD4 C2CD3 NUAK1 UBR5 SEC24B ANKRD17 AGAP1 | 1.05e-07 | 466 | 132 | 14 | M13522 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | IRF2BP2 BCLAF1 BCL9 WNK1 NEDD4 KMT2C PTPRJ WASF2 AUTS2 MLLT3 ZFHX3 MYOCD TNKS1BP1 RNF111 | 1.08e-07 | 467 | 132 | 14 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | IRF2BP2 BCLAF1 BCL9 WNK1 NEDD4 KMT2C PTPRJ WASF2 AUTS2 MLLT3 ZFHX3 MYOCD TNKS1BP1 RNF111 | 1.67e-07 | 484 | 132 | 14 | MM999 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 7.93e-07 | 199 | 132 | 9 | M8115 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRG1 AMPH URI1 CLASP1 WASF3 USP24 ZMIZ1 STIL MED13L NEDD4 C2CD3 NUAK1 UBR5 SEC24B ANKRD17 ZFHX3 AGAP1 | 1.49e-06 | 856 | 132 | 17 | M4500 |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 3.93e-06 | 181 | 132 | 8 | M6849 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN | 7.62e-06 | 198 | 132 | 8 | M6731 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | ARHGAP42 PHACTR2 WASF3 PPP1R13B TACC2 ZMIZ1 MED13L MAGI2 ARHGAP31 MLLT3 ZFHX3 SMAD9 | 1.99e-05 | 542 | 132 | 12 | M19529 |
| Coexpression | RAMASWAMY_METASTASIS_UP | 2.10e-05 | 66 | 132 | 5 | M6698 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.22e-05 | 300 | 132 | 9 | M8702 | |
| Coexpression | LU_EZH2_TARGETS_DN | ZNF280D BCLAF1 TACC2 STIL BCL9 TAB3 SEC24B ANTXR1 ANKRD17 ELF4 | 3.66e-05 | 400 | 132 | 10 | M2140 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.67e-05 | 180 | 132 | 7 | M8239 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP | 4.52e-05 | 186 | 132 | 7 | M9507 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | PHACTR2 NELFA WASF3 PPP1R13B MLXIP MED13L MAGI2 LSR SUDS3 ZFHX3 PRKAG2 TNS3 SMAD9 REV1 | 5.87e-05 | 807 | 132 | 14 | M16651 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 6.74e-05 | 84 | 132 | 5 | M15130 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 7.15e-05 | 200 | 132 | 7 | M8032 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 7.54e-05 | 86 | 132 | 5 | MM825 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IRF2BP2 SGIP1 NBEAL1 PPP1R13B ARHGEF18 SYNPO TENM2 GAB2 MAGI2 KMT2C PER2 PTPRJ ARHGAP31 TRAK2 | 1.07e-04 | 854 | 132 | 14 | M1533 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ROBO4 PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 STIL SIM2 BCL9 ARID1A PRR16 GLI3 MDC1 PLCB1 ANTXR1 TNS3 SMAD9 | 3.04e-06 | 744 | 130 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | ROBO4 PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 SIM2 BCL9 KMT2E PRR16 PLCB1 ANTXR1 ZFHX3 TNS3 SMAD9 | 1.18e-05 | 655 | 130 | 15 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | ROBO4 PHACTR2 COL15A1 SGIP1 ZNF280D BCLAF1 SYNPO ZMIZ1 STIL SIM2 BCL9 KMT2E PRR16 ANTXR1 MLLT3 TNS3 SMAD9 | 1.36e-05 | 834 | 130 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | ROBO4 PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 SIM2 BCL9 KMT2E PLCB1 ANTXR1 MLLT3 TNS3 SMAD9 | 1.62e-05 | 591 | 130 | 14 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | IRF2BP2 SGIP1 ETV5 SYNPO ZMIZ1 MED13L BCL9 KMT2E TENM2 MAGI2 C2CD3 NUAK1 GLI3 AUTS2 MLLT3 ZFHX3 | 1.94e-05 | 769 | 130 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | ROBO4 PHACTR2 COL15A1 SYNPO ZMIZ1 SIM2 PRR16 PTPRJ PLCB1 ANTXR1 ZFHX3 TNS3 SMAD9 | 4.62e-05 | 567 | 130 | 13 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | ROBO4 PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 SIM2 BCL9 PRR16 PTPRJ PLCB1 ANTXR1 TNS3 SMAD9 | 4.75e-05 | 652 | 130 | 14 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | ROBO4 PHACTR2 COL15A1 SYNPO ZMIZ1 SIM2 BCL9 PRR16 PTPRJ PLCB1 ANTXR1 TNS3 SMAD9 | 9.20e-05 | 607 | 130 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | ARHGAP42 IRF2BP2 COL15A1 SGIP1 ZMIZ1 SIM2 BCL9 TENM2 CCNT2 C2CD3 SEC24B AUTS2 MYOCD PRDM16 WNK4 | 1.08e-04 | 795 | 130 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 SIM2 BCL9 KMT2E PRR16 GLI3 ANTXR1 MLLT3 TNS3 SMAD9 | 1.48e-04 | 726 | 130 | 14 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | ROBO4 PHACTR2 COL15A1 SYNPO ZMIZ1 SIM2 PRR16 PTPRJ PLCB1 ANTXR1 TNS3 SMAD9 | 2.73e-04 | 589 | 130 | 12 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CACNB1 SGIP1 SYNPO ZMIZ1 BCL9 CPNE5 TENM2 C2CD3 PTPRJ GLI3 PLCB1 ANTXR1 MLLT3 REPS2 MUC6 SMAD9 | 3.02e-04 | 973 | 130 | 16 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | ROBO4 PHACTR2 COL15A1 SGIP1 SYNPO ZMIZ1 BCL9 PRR16 PLCB1 ANTXR1 TNS3 SMAD9 | 3.04e-04 | 596 | 130 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 3.15e-04 | 149 | 130 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ZNF280D BCLAF1 SYNPO ZMIZ1 STIL SIM2 BCL9 TENM2 PRR16 PTPRJ PLCB1 ANTXR1 REPS2 KIT PRDM16 MUC6 | 3.20e-04 | 978 | 130 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.43e-04 | 98 | 130 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.43e-04 | 98 | 130 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-09 | 187 | 132 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-09 | 199 | 132 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-08 | 186 | 132 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-08 | 188 | 132 | 8 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.47e-08 | 188 | 132 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-07 | 191 | 132 | 8 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-07 | 192 | 132 | 8 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.16e-07 | 193 | 132 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-07 | 193 | 132 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.25e-07 | 195 | 132 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.36e-07 | 197 | 132 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.52e-07 | 200 | 132 | 8 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-07 | 158 | 132 | 7 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 183 | 132 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 183 | 132 | 7 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-06 | 185 | 132 | 7 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 185 | 132 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 185 | 132 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-06 | 185 | 132 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 185 | 132 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-06 | 185 | 132 | 7 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-06 | 186 | 132 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.46e-06 | 187 | 132 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 187 | 132 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.46e-06 | 187 | 132 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 188 | 132 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 188 | 132 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-06 | 188 | 132 | 7 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 132 | 7 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-06 | 190 | 132 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 190 | 132 | 7 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-06 | 190 | 132 | 7 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-06 | 190 | 132 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-06 | 191 | 132 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 191 | 132 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.74e-06 | 192 | 132 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-06 | 192 | 132 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 192 | 132 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-06 | 193 | 132 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.80e-06 | 193 | 132 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.80e-06 | 193 | 132 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.86e-06 | 194 | 132 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.86e-06 | 194 | 132 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-06 | 194 | 132 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.86e-06 | 194 | 132 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 195 | 132 | 7 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 195 | 132 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 196 | 132 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 196 | 132 | 7 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 196 | 132 | 7 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 132 | 7 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-05 | 173 | 132 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 173 | 132 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 177 | 132 | 6 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 177 | 132 | 6 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 177 | 132 | 6 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 178 | 132 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 178 | 132 | 6 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 178 | 132 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.58e-05 | 179 | 132 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 179 | 132 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-05 | 181 | 132 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-05 | 181 | 132 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 182 | 132 | 6 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-05 | 182 | 132 | 6 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 182 | 132 | 6 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.79e-05 | 183 | 132 | 6 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 185 | 132 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-05 | 185 | 132 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 185 | 132 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 185 | 132 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 185 | 132 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 54 | 132 | 4 | 2e177a9fd0f7c033dbcfa8b41b76658d8268644c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 54 | 132 | 4 | 4daa84df51cc99113a9f8e86b1ae09bd76a9c991 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.02e-05 | 187 | 132 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 187 | 132 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 188 | 132 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 188 | 132 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 188 | 132 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 188 | 132 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.08e-05 | 188 | 132 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 188 | 132 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 188 | 132 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-05 | 188 | 132 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 189 | 132 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A | ZNF280D ARHGEF18 GMIP CCNT2 ZFHX3 ELF4 CNOT3 KIF1C RAB11FIP3 | 2.20e-06 | 199 | 130 | 9 | 6268_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.14e-06 | 170 | 130 | 8 | 1050_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 6.41e-06 | 171 | 130 | 8 | 7535_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.69e-06 | 172 | 130 | 8 | 1072_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.44e-05 | 191 | 130 | 8 | 5567_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 1163_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 3909_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 3327_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 1679_DN | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 1.93e-05 | 199 | 130 | 8 | 267_DN | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 7487_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.00e-05 | 200 | 130 | 8 | 1683_UP | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 2.96e-05 | 104 | 130 | 6 | ctd:C000595015 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.41e-06 | 49 | 129 | 5 | DOID:3910 (is_implicated_in) | |
| Disease | cerebral palsy (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | platelet component distribution width | WASF3 ETV5 DOK2 ZMIZ1 ZNF831 WNK1 GAB2 PLCB1 ANTXR1 MLLT3 PRDM16 PEAR1 RAB11FIP3 | 2.81e-05 | 755 | 129 | 13 | EFO_0007984 |
| Disease | small vessel stroke | 6.57e-05 | 96 | 129 | 5 | EFO_1001504 | |
| Disease | Pseudohypoaldosteronism type 2A | 1.13e-04 | 4 | 129 | 2 | cv:C1840389 | |
| Disease | Pseudohypoaldosteronism, type 2 | 1.13e-04 | 4 | 129 | 2 | cv:C1449844 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.18e-04 | 335 | 129 | 8 | EFO_0009931 | |
| Disease | pulse pressure measurement | ARHGAP42 NRG1 COL15A1 SGIP1 NBEAL1 MED13L SRCAP ZNF831 CPNE5 ARHGEF25 PRR16 FASN WASF2 ZFHX3 PRKAG2 PRDM16 TNS3 | 1.23e-04 | 1392 | 129 | 17 | EFO_0005763 |
| Disease | lymphocyte percentage of leukocytes | MINK1 ARHGEF18 ZMIZ1 GMIP ARID1A ZNF831 FASN UBR5 PLCB1 KIT PRDM16 | 1.69e-04 | 665 | 129 | 11 | EFO_0007993 |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.88e-04 | 5 | 129 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.88e-04 | 5 | 129 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NRG1 PER1 TACC2 ZMIZ1 ARID1A WNK1 NEDD4 FASN PER2 CHD5 PLCB1 REPS2 KIT MAP2K7 | 2.63e-04 | 1074 | 129 | 14 | C0006142 |
| Disease | laryngeal carcinoma (is_marker_for) | 2.81e-04 | 6 | 129 | 2 | DOID:2600 (is_marker_for) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 2.81e-04 | 6 | 129 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Calcium channel blocker use measurement | 3.59e-04 | 213 | 129 | 6 | EFO_0009930 | |
| Disease | intraocular pressure measurement | 4.15e-04 | 509 | 129 | 9 | EFO_0004695 | |
| Disease | testosterone measurement | IRF2BP2 ZNF280D ZMIZ1 SRCAP ARID1A SLC30A6 FASN PTPRJ PLCB1 AUTS2 ZFHX3 MYOCD TNKS1BP1 MAP2K7 TNS3 | 4.67e-04 | 1275 | 129 | 15 | EFO_0004908 |
| Disease | interleukin 2 receptor antagonist measurement | 4.82e-04 | 35 | 129 | 3 | EFO_0008332 | |
| Disease | hematocrit | NRG1 NBEAL1 PPP1R13B SYNPO SIM2 SLC4A2 PNPLA1 PTPRJ PLCB1 ANKRD17 MLLT3 PRKAG2 PRDM16 | 5.00e-04 | 1011 | 129 | 13 | EFO_0004348 |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 5.22e-04 | 8 | 129 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | electrocardiography | 5.55e-04 | 530 | 129 | 9 | EFO_0004327 | |
| Disease | 2-hydroxyglutaric acid measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0010446 | |
| Disease | Neurodevelopmental Disorders | 7.54e-04 | 93 | 129 | 4 | C1535926 | |
| Disease | Pseudohypoaldosteronism, Type I | 8.34e-04 | 10 | 129 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 8.34e-04 | 10 | 129 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 8.34e-04 | 10 | 129 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 8.34e-04 | 10 | 129 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 8.34e-04 | 10 | 129 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 8.34e-04 | 10 | 129 | 2 | C1449842 | |
| Disease | Adenoid Cystic Carcinoma | 9.89e-04 | 100 | 129 | 4 | C0010606 | |
| Disease | receptor-interacting serine/threonine-protein kinase 2 measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0802997 | |
| Disease | vital capacity | NRG1 PHACTR2 PER1 ZMIZ1 SIM2 KMT2E TENM2 GLI3 PLCB1 AUTS2 ANTXR1 ZFHX3 ELF4 AGAP1 | 1.05e-03 | 1236 | 129 | 14 | EFO_0004312 |
| Disease | Colorectal Carcinoma | 1.06e-03 | 702 | 129 | 10 | C0009402 | |
| Disease | alcohol consumption measurement | SGIP1 ZNF280D WASF3 PPP1R13B CPNE5 TENM2 MAGI2 PTPRJ GLI3 PLCB1 AUTS2 ZFHX3 KIT PRDM16 | 1.10e-03 | 1242 | 129 | 14 | EFO_0007878 |
| Disease | Antihypertensive use measurement | 1.12e-03 | 265 | 129 | 6 | EFO_0009927 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.15e-03 | 47 | 129 | 3 | C3179349 | |
| Disease | cryptic phenotype measurement | 1.15e-03 | 47 | 129 | 3 | EFO_0021487 | |
| Disease | metabolite measurement, body weight gain | 1.22e-03 | 12 | 129 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | age of onset of multiple sclerosis | 1.22e-03 | 12 | 129 | 2 | OBA_2001029 | |
| Disease | Dupuytren Contracture | 1.32e-03 | 108 | 129 | 4 | EFO_0004229 | |
| Disease | Gastrointestinal Stromal Tumors | 1.38e-03 | 50 | 129 | 3 | C0238198 | |
| Disease | neutrophil percentage of leukocytes | 1.48e-03 | 610 | 129 | 9 | EFO_0007990 | |
| Disease | PR interval | 1.54e-03 | 495 | 129 | 8 | EFO_0004462 | |
| Disease | mean arterial pressure | 1.62e-03 | 499 | 129 | 8 | EFO_0006340 | |
| Disease | red blood cell density measurement | IRF2BP2 NRG1 WNK1 LSR PNPLA1 UBR5 ANTXR1 PRKAG2 TNS3 AGAP1 PEAR1 | 1.71e-03 | 880 | 129 | 11 | EFO_0007978 |
| Disease | prostate carcinoma | BCLAF1 PPP1R13B ZMIZ1 SIM2 SOX13 TAB3 NEDD4 ZFHX3 MYOCD TNS3 SMAD9 | 1.88e-03 | 891 | 129 | 11 | EFO_0001663 |
| Disease | QRS duration | 2.03e-03 | 298 | 129 | 6 | EFO_0005055 | |
| Disease | cognitive behavioural therapy | 2.11e-03 | 58 | 129 | 3 | EFO_0007820 | |
| Disease | white matter hyperintensity measurement | 2.17e-03 | 302 | 129 | 6 | EFO_0005665 | |
| Disease | Cardiovascular Abnormalities | 2.19e-03 | 16 | 129 | 2 | C0243050 | |
| Disease | vision disorder | 2.19e-03 | 16 | 129 | 2 | MONDO_0021084 | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.19e-03 | 16 | 129 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | adverse effect, response to xenobiotic stimulus | 2.22e-03 | 59 | 129 | 3 | EFO_0009658, GO_0009410 | |
| Disease | coronary artery disease | ARHGAP42 HCN4 CIART NBEAL1 FBF1 WASF3 ZNF831 NEDD4 CRACD PTPRJ PRDM16 TNS3 SMAD9 | 2.24e-03 | 1194 | 129 | 13 | EFO_0001645 |
| Disease | cortical surface area measurement | NBEAL1 MED13L TENM2 ZNF469 NUAK1 ARHGAP31 GLI3 MDC1 AUTS2 MLLT3 ZFHX3 PRKAG2 KIT AGAP1 | 2.30e-03 | 1345 | 129 | 14 | EFO_0010736 |
| Disease | hypertension | 2.36e-03 | 307 | 129 | 6 | EFO_0000537 | |
| Disease | white matter integrity | 2.59e-03 | 130 | 129 | 4 | EFO_0004641 | |
| Disease | obesity (implicated_via_orthology) | 2.60e-03 | 215 | 129 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.66e-03 | 131 | 129 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.66e-03 | 131 | 129 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 2.66e-03 | 131 | 129 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.66e-03 | 131 | 129 | 4 | C3714758 | |
| Disease | Feeding difficulties | 2.77e-03 | 18 | 129 | 2 | C0232466 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 2.77e-03 | 18 | 129 | 2 | OBA_2045175 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.80e-03 | 64 | 129 | 3 | DOID:4947 (is_marker_for) | |
| Disease | neutrophil count | SGIP1 DOK2 PLEKHG2 ZMIZ1 BCL9 KMT2E ARID1A LRIG2 PTPRJ PLCB1 KIT CCDC9 TNS3 PEAR1 | 2.94e-03 | 1382 | 129 | 14 | EFO_0004833 |
| Disease | Juvenile-Onset Still Disease | 2.97e-03 | 135 | 129 | 4 | C0087031 | |
| Disease | cigarettes per day measurement | 3.21e-03 | 438 | 129 | 7 | EFO_0006525 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.29e-03 | 139 | 129 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | schizophrenia (implicated_via_orthology) | 3.33e-03 | 68 | 129 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | IRF2BP2 ATN1 CLASP1 SLC4A2 UBR5 PLCB1 ANTXR1 PRKAG2 PRDM16 MAP2K7 TNS3 AGAP1 | 3.38e-03 | 1105 | 129 | 12 | EFO_0004528 |
| Disease | Intellectual Disability | 3.59e-03 | 447 | 129 | 7 | C3714756 | |
| Disease | cardiovascular disease | 4.05e-03 | 457 | 129 | 7 | EFO_0000319 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.14e-03 | 22 | 129 | 2 | EFO_0009312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFPLHSPTRPPSPAS | 41 | Q6ZS49 | |
| PTSNPVPASPINFHP | 96 | Q6N043 | |
| TTSPKLNPPPSPHAN | 361 | Q96P64 | |
| ASPPHPPTTPQYSTQ | 11 | Q5W0A0 | |
| SPTRPPLASPTHYAP | 211 | Q9UGJ0 | |
| PSSPAPLPHQEATPR | 171 | P04920 | |
| FNPHFISLPPSTPPT | 391 | Q6UXE8 | |
| DTLAEAQPPSHPPSF | 1156 | Q6ZSZ5 | |
| HSVPATPTSTPVPNP | 106 | Q96FF9 | |
| SSHNSVFNHPLPPPP | 656 | O60583 | |
| TTSPKLDPPPSPHAN | 511 | Q9UPQ3 | |
| QAPHDSPPVSPTPKT | 551 | Q86VW2 | |
| PLNNAYHTSSPPPAP | 496 | Q9H6X2 | |
| HTAEPPLSLPPSEPN | 616 | A6NF34 | |
| ATHPPSSTPPNPLLN | 411 | Q02641 | |
| DPNTPVPASPAHLLP | 1546 | Q8TDI0 | |
| PPQPTAAHSSATPVP | 996 | Q8IZF6 | |
| SKPPPDNIPPASSTH | 1146 | Q8IZF6 | |
| SSASSPLHHEPPPPL | 456 | P42568 | |
| PFPPSTGAQSTAHPP | 461 | P54259 | |
| APPPDVTQLTPPSHD | 726 | O75179 | |
| PSPARLSQTPHSQPP | 701 | Q9UER7 | |
| APLPPASHPPATSTN | 851 | Q96KQ4 | |
| TTSPKLNPPPSPHAN | 361 | Q5VW22 | |
| EPSPLPSPTASPNHT | 266 | P49418 | |
| PHNPPPSTSKEPSAA | 461 | O75175 | |
| PVNPPSSPTPSFSDA | 501 | O75175 | |
| QIPDPPFSSPITPHR | 726 | Q6ZS30 | |
| PPQPSDLSQTHPLPS | 181 | O75154 | |
| PDQNSPTLPPRTSHP | 291 | Q9UL03 | |
| ATPLHFPPSPFPSST | 766 | Q9H3S7 | |
| PVDFHTPSSPKSPPS | 436 | Q02297 | |
| PAQSPFSPHTSPHLP | 676 | O14497 | |
| PSHPETTLPTHVPPF | 1436 | Q6W4X9 | |
| PPFTTHSPPTGSSPF | 1571 | Q6W4X9 | |
| PPPPDGSPNITSVSH | 816 | Q12913 | |
| YSRPHDSLPPPSPTT | 271 | O60496 | |
| NPTAASESPFSPPHP | 181 | P10071 | |
| HSPPLIHPAPTFPTQ | 376 | P10071 | |
| APSTPHSDITAPPTP | 3621 | Q8NEZ4 | |
| PTPPSLEQHPAFSPV | 866 | Q71F56 | |
| TPFPATSAAPEPHPS | 1116 | Q14676 | |
| SPSHPAPPSDPSHQI | 1266 | Q86UL8 | |
| APPSDPSHQISPGPT | 1271 | Q86UL8 | |
| FPSPPPSSNLDVPTH | 701 | P46934 | |
| HNLPPFTPPPHTEDS | 266 | Q09161 | |
| PEEPSAPSPTLPAQF | 356 | Q9H3P2 | |
| QPSVSPGEPSPPSIH | 26 | P10721 | |
| SPTPAPFSPFNPTSL | 641 | Q99607 | |
| TTSSQPPPPHLDPDS | 781 | Q9P107 | |
| TPPPQAPSPAHSFNK | 186 | P0C7T5 | |
| SHSPSPSLPALAPSP | 951 | O15534 | |
| AAPPAPPHASFTVPA | 866 | O15055 | |
| PSSESSPQHPTPPAR | 56 | O14733 | |
| SYHTLSQCSPNPPPP | 821 | Q5VY43 | |
| PSASPFPLSLPNHSP | 426 | Q8WXX7 | |
| PVSFPAVHKPPSSTP | 371 | Q8N8W4 | |
| SPPAPVSPSSPTTHN | 406 | O43896 | |
| PSSAHPTVPPYPSQA | 1751 | Q8IZD2 | |
| PPTTPLSPTHQNPLF | 136 | P41161 | |
| HSETPAAPALPPSAP | 146 | O75167 | |
| EHFLPPPPSSRSPSS | 956 | Q9Y3Q4 | |
| LPPSPNNPHFLPSSS | 651 | Q8IZQ8 | |
| PATALNPPAPPTFHQ | 456 | Q9HAP2 | |
| PVTPSVPPPASQHST | 371 | Q8TES7 | |
| HLEPSPPASPTQSPD | 466 | P24394 | |
| PNRKSPSPVAPHPST | 766 | Q4AC94 | |
| PSPVAPHPSTFVATP | 771 | Q4AC94 | |
| HPSHQPPASTLSPNP | 206 | A6NFR6 | |
| PSSPFSPPSGHQPVS | 486 | Q9Y3X0 | |
| HMPPLPLNPSSNPTS | 816 | O00512 | |
| NSPRSPHSPSPIATP | 221 | Q9NYF8 | |
| PHSPSPIATPPSQSS | 226 | Q9NYF8 | |
| PPPASSQTPAPEHDK | 936 | Q6ZU35 | |
| HSLPQGPPSPEPDFS | 731 | Q9UJ99 | |
| KASPAPPRHTPDQSP | 51 | Q7Z2K8 | |
| PRLFDHPESPTPNPT | 966 | P49327 | |
| HPESPTPNPTEPLFL | 971 | P49327 | |
| ADSPPPPALSSNPHQ | 1186 | P39059 | |
| NTAISHPSPLPPLPS | 231 | O95487 | |
| SFVSPPPPTASPHSN | 396 | Q7Z5L9 | |
| QSHPPAPPVQAPSTS | 401 | Q5FWE3 | |
| APTHSPSQSPARTPP | 571 | Q9HCH3 | |
| PSQSPARTPPASPLH | 576 | Q9HCH3 | |
| STYAHLSPAKTPPPP | 326 | Q86X29 | |
| QHPEASPPFSIPSPS | 1076 | A6NGG8 | |
| SHDPDPAIPAPTATP | 616 | Q8N4C8 | |
| PSHSSQPTLFTFEPP | 161 | Q9UQC2 | |
| LAPDSPAPAQTPPLH | 371 | Q96NZ1 | |
| FVSPSLTPPPAIAHP | 486 | O94763 | |
| PPSQCPSPFSSPQHQ | 296 | Q8N5C8 | |
| IFHTAPDPSIPLPQP | 571 | A6NI28 | |
| QSSPAPPPAEVHSPA | 296 | Q8N3V7 | |
| GTPQDSPLPAHTPPS | 486 | O15353 | |
| HSNSFPPIRPATVPP | 271 | Q569H4 | |
| PSPSPPSLQATPHTL | 501 | Q9H6K5 | |
| PHSLTSPSLQAPPSP | 591 | Q9H6K5 | |
| PHHPFNFRSPPPTLS | 926 | Q9HAZ2 | |
| PPASAAAPPELQPHS | 411 | Q14190 | |
| PSAQLPSSHNPPPVS | 181 | Q9NT68 | |
| IPSPSPPDPARVTSH | 501 | O60285 | |
| TPQSSPAMPLAPSHP | 836 | Q9NQW1 | |
| PSPLPHSSPPTAAVA | 956 | Q14160 | |
| AVPTSHPPEDAPAQP | 1326 | Q14160 | |
| NSESRTQPPPHPSPL | 2961 | Q6ZRS2 | |
| PHPPDTQQPSPSKAF | 651 | Q68CZ2 | |
| SPPEPPLSSPASQHK | 866 | Q68CZ2 | |
| PAPLFPHETPPTQSQ | 716 | Q8WZ75 | |
| FQQPPCSALPPSPSH | 181 | O15198 | |
| TQSPPELAPAPSAFP | 321 | E9PGG2 | |
| QPFTHSAPTTPVPPT | 301 | Q8N365 | |
| AKHPPPFSQPNSIPT | 1136 | Q7Z460 | |
| LAIPSTPPNSPSHSP | 771 | O60296 | |
| DFSPRPIPSPHPVSQ | 401 | Q15468 | |
| PHSNIEPSPVARPPS | 676 | Q15468 | |
| AFPPSHQPLPVTPDS | 231 | Q9UN79 | |
| SPLASPPSSPPHYQR | 191 | Q8NFH8 | |
| TPHPAVPVSPSFSDP | 521 | Q6ZNA4 | |
| LPPFPAHLPTSPDTN | 891 | Q9UBZ9 | |
| HSVPQPTTAIPAFPP | 346 | O14776 | |
| QAIHSPAPQSPAPSP | 356 | A6NFA1 | |
| TTASPPPLPLQPTHS | 451 | A6NFA1 | |
| VSRPFSPPIHSSSPP | 481 | Q9BQI5 | |
| EPHSLDQPPATSPRP | 376 | Q9C0C2 | |
| PATPNHSLHPQPVTP | 251 | Q9UPY6 | |
| PSPPPSQEREHPSSS | 96 | O95359 | |
| SPPFPIMDHLPPSST | 1351 | Q2M1Z3 | |
| ASPHSSPPPLPAKAS | 941 | Q86UU1 | |
| TPKPPSQALHSQPAP | 871 | Q9NQ66 | |
| SSPSPSFSEDNLPPP | 256 | Q9Y6W5 | |
| HPPTHPQETGSPFPS | 636 | Q96JG9 | |
| PSNHQECPPPSLSPF | 3516 | Q96JG9 | |
| TPAKPSSPPPEFSFN | 376 | Q6NXT4 | |
| PSSPEISPQSSPRPH | 2071 | Q9UPU5 | |
| LESSDLTPPHSPPPS | 1251 | Q9H7P9 | |
| SIPAAVPQSAPPEPH | 106 | Q9H4A3 | |
| PAPAEHPSLATPPQA | 911 | Q5JPB2 | |
| RPASPSSPEHLPATP | 231 | Q9H7L9 | |
| SDPPSPPVLNNSHPV | 651 | O60293 | |
| SSNPSPHPTSSPLPF | 851 | Q96J92 | |
| DNPFSPPRTLHSPPL | 1141 | Q6PFW1 | |
| ASPHSTAPSPTPSFP | 336 | Q7Z7K2 | |
| PCPAFSSHNSSSPPP | 146 | Q8IZ20 | |
| IPPHTRPPADFTQPA | 266 | Q9ULJ6 | |
| SDHQDPVSPPIAPPS | 1011 | O95071 | |
| AHSNDSPPPPSAAAP | 3591 | Q15911 | |
| HAPAPSEPDATPLPT | 176 | Q5T230 | |
| LPHPPFSQQPVHESP | 1006 | O94898 | |
| PLPPPPSSGDSNSHF | 476 | Q96HR8 |